THC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
THC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Tenet Healthcare's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $3,453 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.
Total Stockholders Equity is used to calculate Book Value per Share. Tenet Healthcare's Book Value per Share for the quarter that ended in Mar. 2024 was $35.35. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Tenet Healthcare's Debt-to-Equity for the quarter that ended in Mar. 2024 was 3.73.
The historical data trend for Tenet Healthcare's Total Stockholders Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tenet Healthcare Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Total Stockholders Equity | Get a 7-Day Free Trial | -417.00 | 28.00 | 1,028.00 | 1,142.00 | 1,608.00 |
Tenet Healthcare Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Total Stockholders Equity | Get a 7-Day Free Trial | 1,233.00 | 1,343.00 | 1,464.00 | 1,608.00 | 3,453.00 |
Tenet Healthcare (NYSE:THC) Total Stockholders Equity Explanation
1. Total Stockholders Equity is used to calculate Book Value per Share.
Tenet Healthcare's Book Value per Share for the quarter that ended in Mar. 2024 is
Book Value per Share | = | (Total Stockholders Equity | - | Preferred Stock) | / | Shares Outstanding (EOP) |
= | (3453 | - | 0) | / | 97.673 | |
= | 35.35 |
2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.
Tenet Healthcare's Debt-to-Equity for the quarter that ended in Mar. 2024 is
Debt-to-Equity | = | Total Debt | / | Total Stockholders Equity | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | Total Stockholders Equity | |
= | (107 | + | 12772) | / | 3453 | |
= | 3.73 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Tenet Healthcare's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.
Richard W Fisher | director | |
Roy Blunt | director | 2702 LOVE FIELD DRIVE, HDQ 4GC, DALLAS TX 75235 |
Paola M Arbour | officer: EVP, Chief Information Officer | 14201 DALLAS PARKWAY, DALLAS TX 75254 |
Stephen H Rusckowski | director | C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094 |
Thomas W Arnst | officer: EVP, Chief Admin. Officer & GC | 14201 DALLAS PARKWAY, DALLAS TX 75254 |
Tammy Romo | director | C/O SOUTHWEST AIRINES CO., 2702 LOVE FIELD DR., DALLAS TX 75235 |
Daniel J Cancelmi | officer: Principal Accounting Officer | 13737 NOEL ROAD, SUITE 100, DALLAS TX 75240 |
J Robert Kerrey | director | NEW SCHOOL UNIVERSITY, 66 W. 12TH STREET, NEW YORK NY 10036 |
Richard J Mark | director | 1901 CHOUTEAU AVENUE MC-1310, ST. LOUIS MO 63103 |
Ronald A Rittenmeyer | director | 5400 LEGACY DRIVE, PLANO TX 75024 |
Lisa Y Foo | officer: EVP, Commercial Ops | 14201 DALLAS PARKWAY, DALLAS TX 75254 |
Audrey T. Andrews | officer: SVP and General Counsel | 1445 ROSS AVENUE, SUITE 1400, DALLAS TX 75202 |
Meghan Fitzgerald | director | C/O VION PHARMACEUTICALS, INC., 4 SCIENCE PARK, NEW HAVEN CT 06511 |
Howard Hacker | officer: EVP, Chief Compliance Officer | 14201 DALLAS PARKWAY, DALLAS TX 75254 |
Marie Quintana | officer: EVP, Marketing/Communications | 14201 DALLAS PARKWAY, DALLAS TX 75254 |
From GuruFocus
By Business Wire Business Wire • 01-17-2023
By GuruFocus Research • 10-11-2023
By Business Wire Business Wire • 04-27-2023
By Business Wire Business Wire • 01-30-2023
By Business Wire • 08-10-2023
By GuruFocus Research • 11-18-2023
By Business Wire • 06-23-2023
By GuruFocus Research • 11-15-2023
By Business Wire Business Wire • 05-02-2023
By Business Wire Business Wire • 01-19-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.